Utah Medical Products (UTMD) Key Ratios

$68.08

up-down-arrow $1.28 (1.91%)

As on 30-Oct-2026 16:00EST

Market cap

info icon

$194 Mln

Revenue (TTM)

info icon

$35 Mln

P/E Ratio

info icon

20.4

P/B Ratio

info icon

1.8

Div. Yield

info icon

0.5 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 1.08 -12.14 -9.62 -12.13 -6.22
EBIT 3.50 2.78 -6.51 -14.20 -6.50
Net Profit 3.76 5.93 -8.42 -14.29 -5.43
EPS 3.88 6.82 -5.51 -10.43 -2.80
Book Value -- -- 7.60 5.87 5.78
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info 38.1038.5437.1636.6341.08
Net Margin info --30.7630.48----
Return on equity info 11.5112.708.749.5411.29
Return on Capital info 11.4912.67--9.5111.26
Return on Assets info 10.9311.916.019.2110.76
Debt to Equity (x) info ----0.000.000.00
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
--
9.51
11.26
13.68
14.83
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

8.74

Higher than Peers by 3.55

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
8.74
9.54
11.29
13.72
14.88
Peer Median
5.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

6.01

Higher than Peers by 3.38

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
6.01
9.21
10.76
12.83
13.76
Peer Median
2.63
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

37.16

Higher than Peers by 28.17

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
37.16
36.63
41.08
36.60
39.52
Peer Median
8.99
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

30.48

Higher than Peers by 25.17

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
30.48
29.30
33.92
33.12
31.38
Peer Median
5.31
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

-9.62

Lower than Peers by 18.88

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
-9.62
-0.06
-0.19
-0.04
0.07
Peer Median
9.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-6.51

Lower than Peers by 19.88

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
-6.51
-16.02
-8.61
-11.01
8.38
Peer Median
13.37
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-8.42

Lower than Peers by 24.25

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
-8.42
-18.65
-16.60
0.98
11.39
Peer Median
15.83
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-5.51

Lower than Peers by 28.66

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
-5.51
-0.14
-0.11
0.01
0.12
Peer Median
23.15
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

5.13

Lower than Peers by 2.52

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
5.13
--
--
--
--
Peer Median
7.64
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
--
0.00
0.00
0.00
0.00
Peer Median
0.37
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
--
--
0.00
0.00
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

21.23

Higher than Peers by 18.41

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
21.23
37.62
25.64
22.56
15.09
Peer Median
2.82
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

19.00

Higher than Peers by 16.91

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
19.00
34.57
23.29
20.53
13.61
Peer Median
2.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
--
--
--
--
23.77
Peer Median
5.21
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

11.34

Lower than Peers by 5.11

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
11.34
9.14
10.01
6.75
10.59
Peer Median
16.45
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.20

Lower than Peers by 0.31

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
0.20
0.31
0.32
0.39
0.44
Peer Median
0.50
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
--
36.11
33.41
32.46
37.27
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
--
185.15
200.43
166.43
140.12
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
--
16.07
14.30
17.98
17.99
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
--
205.18
219.55
180.92
159.39
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

20.38

Lower than Peers by 27.72

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
20.38
15.86
15.01
18.37
22.18
Peer Median
48.10
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

1.76

Lower than Peers by 1.73

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
1.76
1.50
1.77
2.38
3.20
Peer Median
3.48
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

0.46

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
0.46
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

12.57

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
12.57
5.48
6.39
1.10
10.48
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

194

Lower than Peers by 405

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Utah Medical Products (UTMD)
194
--
--
--
--
Peer Median
599
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds